CLINICAL MICROBIOLOGY REVIEWS

Scope & Guideline

Unraveling the complexities of infectious diseases.

Introduction

Delve into the academic richness of CLINICAL MICROBIOLOGY REVIEWS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0893-8512
PublisherAMER SOC MICROBIOLOGY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1988 to 2024
AbbreviationCLIN MICROBIOL REV / Clin. Microbiol. Rev.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1752 N ST NW, WASHINGTON, DC 20036-2904

Aims and Scopes

The journal 'Clinical Microbiology Reviews' serves as a comprehensive platform for disseminating critical reviews and insights into the field of clinical microbiology. It aims to enhance understanding of microbial infections, their management, and the evolving challenges posed by antimicrobial resistance and emerging pathogens.
  1. Clinical Microbiology and Infectious Disease Management:
    Focuses on the diagnosis, treatment, and prevention of infectious diseases, providing updates on clinical practices and laboratory methods.
  2. Antimicrobial Resistance and Stewardship:
    Addresses the growing concern of antimicrobial resistance, exploring mechanisms, implications for treatment, and strategies for stewardship in clinical settings.
  3. Microbiome Research:
    Investigates the role of the human microbiome in health and disease, emphasizing its implications for treatment and prevention strategies.
  4. Emerging Pathogens and Public Health Concerns:
    Covers newly identified pathogens and their public health implications, including responses to outbreaks and the development of vaccines.
  5. Innovative Therapeutic Approaches:
    Highlights novel treatment modalities and technologies, including phage therapy, mRNA vaccines, and bioengineering strategies for infectious disease management.
  6. Clinical Laboratory Innovations:
    Focuses on advancements in laboratory diagnostics, biosafety, and methodologies that enhance the detection and management of infectious diseases.
The journal is currently witnessing a surge in specific themes that reflect the dynamic landscape of clinical microbiology and infectious disease research. These emerging areas are crucial for addressing contemporary challenges in the field.
  1. COVID-19 and Viral Infections:
    Research related to COVID-19, including diagnostics, treatment strategies, and public health responses, has seen a significant increase following the pandemic.
  2. Microbiome and Health Interactions:
    The exploration of the human microbiome's role in health, disease, and therapeutic outcomes is gaining traction, highlighting its importance in clinical practice.
  3. Innovations in Vaccine Development:
    There is a growing emphasis on novel vaccine technologies, particularly mRNA vaccines, in response to emerging infectious diseases and public health needs.
  4. Antimicrobial Resistance Strategies:
    A heightened focus on understanding and combating antimicrobial resistance, including novel therapeutic approaches and stewardship practices, is emerging.
  5. Public Health Surveillance and Preparedness:
    Research on surveillance methodologies, including wastewater-based surveillance and responses to outbreaks, is increasingly relevant in the context of global health security.

Declining or Waning

While 'Clinical Microbiology Reviews' continues to evolve, certain themes have become less prominent over recent years. This decline may reflect shifts in research focus or advancements in other areas of microbiology.
  1. Traditional Antibiotics:
    Research on conventional antibiotic treatments is declining as the field pivots towards exploring alternatives and addressing antibiotic resistance.
  2. Non-Emerging Infectious Diseases:
    Infectious diseases that have been historically well-managed (e.g., certain bacterial infections) are receiving less attention compared to emerging threats like COVID-19 and antimicrobial resistance.
  3. Basic Microbiology Research:
    There is a noticeable shift away from fundamental microbiological studies towards more clinical and applied research, reflecting the journal's focus on direct clinical implications.
  4. Single-Pathogen Studies:
    Focus on studies of individual pathogens is waning as there is a growing interest in co-infections, interactions within the microbiome, and systems biology approaches.

Similar Journals

Infectious Microbes & Diseases

Exploring innovative solutions to global health challenges.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 4 issues/year

Infectious Microbes & Diseases, published by Lippincott Williams & Wilkins, is a premier journal dedicated to the exploration and understanding of infectious diseases, microbiology, and epidemiology. With its focused scope and robust peer-review process, the journal aims to disseminate high-quality research that contributes to advancements in the field, making it an essential resource for researchers, healthcare professionals, and students alike. Established in 2019, it has quickly gained recognition, achieving a Q3 rating in categories such as Epidemiology, Infectious Diseases, and Medical Microbiology in 2023, and ranking in the top half of its field within Scopus metrics. Although currently offered as a subscription-based journal, Infectious Microbes & Diseases significantly enriches its disciplines by inviting innovative research and critical review articles, thus playing a vital role in combating the global challenges posed by infectious diseases.

MIKROBIYOLOJI BULTENI

Elevating Scientific Discourse in Microbiology
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

REVISTA ARGENTINA DE MICROBIOLOGIA

Championing the dissemination of vital microbiological discoveries.
Publisher: ASOCIACION ARGENTINA MICROBIOLOGIAISSN: 0325-7541Frequency: 4 issues/year

REVISTA ARGENTINA DE MICROBIOLOGIA, published by the ASOCIACION ARGENTINA MICROBIOLOGIA, stands as a prominent open-access journal in the field of microbiology and medicine since its establishment in 1979. With an ISSN of 0325-7541 and an E-ISSN of 1851-7617, this journal has paved the way for disseminating high-quality research while enhancing accessibility for academics and practitioners worldwide. The journal has achieved notable rankings, being classified in Q3 for Medicine (miscellaneous) and Q3 for Medical Microbiology in 2023, reflecting its commitment to advancing knowledge in these critical areas. Despite its relatively modest impact factors, it occupies a vital niche in the academic landscape, fostering collaborations and innovative research among experts. With Open Access available since 2013, REVISTA ARGENTINA DE MICROBIOLOGIA not only facilitates widespread distribution of valuable scientific information but also empowers researchers, professionals, and students to stay abreast of the latest findings and developments in microbiology. For those engaged in the evolving realm of microbiology, this journal serves as an essential resource for sharing insights and advancing the scientific community.

Infectious Diseases and Clinical Microbiology

Transforming discoveries into clinical applications for better health.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 2667-646XFrequency: 4 issues/year

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

Mediterranean Journal of Infection Microbes and Antimicrobials

Advancing knowledge in infection and microbiology.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Indian Journal of Medical Microbiology

Your Gateway to Open Access Microbiological Research
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

Microbiology Spectrum

Fostering collaboration through open access innovation.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

CLINICAL MICROBIOLOGY AND INFECTION

Elevating Standards in Microbial Research
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

Klimik Journal

Fostering Innovation in Medical Microbiology.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 1301-143XFrequency: 4 issues/year

Klimik Journal is a pivotal publication in the fields of Infectious Diseases and Medical Microbiology, serving as a platform for researchers, clinicians, and academics to disseminate groundbreaking findings and improve health outcomes. Established in 2010 and published by DOC DESIGN INFORMATICS CO LTD, this journal is dedicated to advancing knowledge and fostering discussions around critical issues in infectious diseases and microbial research. With an ISSN of 1301-143X and an E-ISSN of 1309-1484, Klimik Journal strives to maintain high academic standards despite currently ranking in the fourth quartile in both categories according to Scopus metrics, which highlights the need for continued contributions to the field. Operating from Turkey, the journal is committed to supporting open access options, thereby ensuring wide dissemination of research findings. As it continues to bridge the gap between theory and practice, Klimik Journal is poised to become an essential resource for those looking to stay at the forefront of infectious disease research and microbiological advancements.

Brazilian Journal of Infectious Diseases

Empowering healthcare through innovative research and insights.
Publisher: ELSEVIER BRAZILISSN: 1413-8670Frequency: 6 issues/year

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.